WallStreetZenWallStreetZen

NASDAQ: UBX
Unity Biotechnology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for UBX

Based on 6 analysts offering 12 month price targets for Unity Biotechnology Inc.
Min Forecast
$3.00-0.33%
Avg Forecast
$7.50+149.17%
Max Forecast
$10.00+232.23%

Should I buy or sell UBX stock?

Based on 6 analysts offering ratings for Unity Biotechnology Inc.
Strong Buy
Strong Buy
3 analysts 50%
Buy
3 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UBX stock forecasts and price targets.

UBX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Roth MKM
Bottom 46%
46
Strong BuyInitiates Coverage On$10.00+232.23%2023-05-31
Citigroup
Top 45%
56
Strong BuyMaintains$6.00+99.34%2023-05-26
HC Wainwright & Co.
Top 13%
88
BuyReiterates$10.00+232.23%2023-05-10
Wedbush
Top 16%
85
BuyMaintains$3.00-0.33%2023-04-25
Mizuho
Bottom 6%
6
Strong BuyMaintains$6.00+99.34%2023-03-28
HC Wainwright & Co.
Top 16%
85
BuyReiterates$10.00+232.23%2023-03-16

1 of 1

Forecast return on equity

Is UBX forecast to generate an efficient return?
Company
N/A
Industry
0.07%
Market
70.69%

Forecast return on assets

Is UBX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.1%

UBX revenue growth forecast

How is UBX forecast to perform vs Biotechnology companies and vs the US market?
Company
852.6%
Industry
39.55%
Market
8.41%
UBX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UBX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UBX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
UBX$3.01$7.50+149.17%Strong Buy
CADL$1.51$7.00+363.58%Buy
NCNA$0.84$4.00+379.04%Buy
OKYO$1.56N/AN/A
GRNA$0.29$0.30+2.74%Hold
View Top Biotech Stocks

Unity Biotechnology Stock Forecast FAQ

Is Unity Biotechnology Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: UBX) stock is to Strong Buy UBX stock.

Out of 6 analysts, 3 (50%) are recommending UBX as a Strong Buy, 3 (50%) are recommending UBX as a Buy, 0 (0%) are recommending UBX as a Hold, 0 (0%) are recommending UBX as a Sell, and 0 (0%) are recommending UBX as a Strong Sell.

If you're new to stock investing, here's how to buy Unity Biotechnology stock.

What is UBX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: UBX) forecast ROE is N/A, which is considered weak.

What is UBX's Price Target?

According to 6 Wall Street analysts that have issued a 1 year UBX price target, the average UBX price target is $7.50, with the highest UBX stock price forecast at $10.00 and the lowest UBX stock price forecast at $3.00.

On average, Wall Street analysts predict that Unity Biotechnology's share price could reach $7.50 by May 31, 2024. The average Unity Biotechnology stock price prediction forecasts a potential upside of 149.17% from the current UBX share price of $3.01.

What is UBX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: UBX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.